MicroPort Science Corporation was founded in Shanghai in 1998

[moniya12]

According to the company, about 100,000 critically ill patients have been treated with NeuroTech's drugs in about 2,000 local hospitals in 31 provinces and cities.

It has acquired more than 100 patents at home and abroad and is registered as a pilot high-tech company for building a scientific innovation center with global influence in Shanghai.

The company also invested in Israeli technology firm Rapid Medical and became its majority shareholder to streamline its production lines. Tigertriever's key product, a new embolism stent, has been approved for China's National Medical Products Administration's special approval procedure for innovative medical devices.

“Stroke is one of the most deadly diseases in the world after cardiovascular disease, and the incidence of stroke in China is the highest in the world,” said Xie Zhien, president of NeuroTech.

Over the past three decades, more and more young people in paraguay telegram number database China have suffered from brain strokes, requiring more intervention devices, Xie said.

. It has become a leading medical device company, producing the world's first targeted drug delivery stent and China's first pacemaker manufactured to international standards.

Zhangjiang, located in the Pudong New Area, is a shining star of urban innovation. As a former national center for scientific and technological development, it is now home to many innovation centers. These include the Shanghai Synchrotron Radiation Facility (SSRF), China’s largest synchrotron research center, often referred to as the “Shanghai Light Source,” and a lab that has created a new drug for Alzheimer’s disease.

Zhangjiang is home to integrated circuit firms spanning the entire industry, including designers and manufacturers of chips for smartphones and automobiles. Nine chip firms headquartered in Zhangjiang are listed on Shanghai's STAR Market, an exchange for firms with core technologies and innovations.

[HJnediodcc]

MicroPort Science Corporation, founded in Shanghai in 1998, has significantly contributed to advancements in medical technology. Their focus on innovation aligns with the growing importance of medical device integration, which plays a critical role in enhancing patient care and treatment efficiency in today's healthcare systems.